Advertisement
Screener

MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

MATINAS BIOPHARMA HOLDINGS, INC. Cash Flow Breakdown

Cash flow breakdown shows where MATINAS BIOPHARMA HOLDINGS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $7.01M went out.
  • Fiscal year ended 2025-12-31: from investing, $335.00K came in.
  • Fiscal year ended 2025-12-31: from financing, $3.39M came in.
  • Fiscal year ended 2025-12-31: change in cash, $3.29M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$7.01M$335.00K$3.39M*-$3.29M
2024-12-31-$15.88M$9.21M$9.18M$2.50M
2023-12-31-$15.28M$13.24M-$2.04M
2022-12-31-$19.16M$4.88M$99.00K-$14.20M
2021-12-31-$15.22M$16.77M$1.42M$5.55M*$8.51M
2020-12-31-$17.37M-$40.67M$599.71K$47.45M*-$9.99M
2019-12-31-$14.09M-$6.01M$30.18K$29.82M*$9.75M
2018-12-31-$10.32M-$535.92K$15.87M*$5.01M
2017-12-31-$11.46M-$942.18K$15.60M*$3.20M
2016-12-31-$6.12M$0.00$0.00$7.00M*$878.45K
2015-12-31-$7.81M-$5.42K$10.00M-$1.54M*$636.28K
2014-12-31-$7.96M-$288.52K$0.00-$8.25M
2013-12-31-$2.99M-$94.19K$15.00M-$1.50M*

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$1.84M*
2026-03-31-$1.60M-$1.60M
2025-12-31-$1.51M*$15.00K*
2025-09-30-$1.47M*
2025-06-30-$2.02M*$1.62M*
2025-03-31-$2.01M$1.65M*-$360.00K
2024-12-31-$3.51M*$500.00K*$0.00*
2024-09-30-$3.50M*$9.65M*-$65.00K*
2024-06-30-$3.11M*-$2.94M*$9.19M*
2024-03-31-$5.77M$2.00M$54.00K-$3.72M
2023-12-31-$4.58M*$2.96M*
2023-09-30-$4.42M*$1.08M*
2023-06-30-$2.19M*$6.20M*
2023-03-31-$4.09M$3.00M-$1.09M
2022-12-31-$4.30M*-$42.00K*$0.00*
2022-09-30-$4.97M*$5.75M*$0.00*
2022-06-30-$5.13M*-$3.79M*$0.00*
2022-03-31-$4.76M$2.96M$99.00K-$1.70M
2021-12-31-$3.96M*$56.65K*$14.34K*
2021-09-30-$5.75M*$242.69K*$0.00*
2021-06-30-$864.65K*$7.65M*$188.63K*
2021-03-31-$4.65M$8.82M$1.21M$5.57M*$10.95M
2020-12-31-$4.31M*$9.09M*$492.39K*
2020-09-30-$5.23M*-$2.78M*$64.83K*
2020-06-30-$3.17M*$7.99M*$0.00*
2020-03-31-$4.66M-$54.97M$42.50K$47.40M*-$12.19M
2019-12-31-$4.90M*-$5.61M*
2019-09-30-$4.07M*-$73.43K*
2019-06-30-$2.10M*-$317.93K*
2019-03-31-$3.02M-$14.25K$30.03M*$26.99M
2018-12-31-$2.62M*$0.00*$8.36M*
2018-09-30-$2.64M*-$275.31K*$642.50K*
2018-06-30-$2.26M*-$158.69K*$7.00M*
2018-03-31-$2.81M-$101.92K-$3.04M
2017-12-31-$1.92M*-$118.29K*-$1.69M*
2017-09-30-$2.78M*-$34.18K*$553.19K*-$2.27M*
2017-06-30-$3.73M*-$4.57M*
2017-03-31-$3.03M$14.76M*$11.73M
2016-12-31-$2.12M*$0.00*$0.00*-$2.11M*
2016-09-30-$1.37M*$0.00*$0.00*$7.01M*$5.64M*
2016-06-30-$1.09M*$0.00*$0.00*-$1.09M*
2016-03-31-$1.54M$0.00$0.00-$1.55M
2015-12-31-$1.12M*-$22.93K*$0.00*-$1.14M*
2015-09-30-$2.16M*-$14.51K*$1.48M*-$2.24M*
2015-06-30-$2.22M*-$33.89K*$4.24M*$1.99M*
2015-03-31-$2.32M$65.91K$4.28M$2.03M
2014-12-31-$2.42M*-$1.00*$0.00*-$2.42M*
2014-09-30-$1.61M*-$30.75K*$0.00*-$1.64M*
2014-06-30-$1.85M*-$64.50K*$0.00*-$1.91M*
2014-03-31-$2.09M-$193.28K$0.00-$2.28M
2013-12-31-$1.67M*-$65.89K*$0.00*
2013-09-30-$886.95K*-$28.30K*$13.03M*
2013-06-30-$284.49K*$0.00*
2013-03-31-$150.12K$0.00$0.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
Genprex, Inc. (GNPX)United States$0.003B-0.02
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
ORAGENICS INC (OGEN)United States$0.002B
Nexentis Technologies Inc. (NXTS)$0.002B